Results 1 to 10 of about 6,959 (172)

Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: A cohort study. [PDF]

PLoS Medicine, 2018
BackgroundMultimorbidity is increasingly common and is associated with adverse health outcomes, highlighting the need to broaden the single-disease framework that dominates medical research.
Archana Singh-Manoux, Aurore Fayosse, Séverine Sabia, Adam Tabak, Martin Shipley, Aline Dugravot, Mika Kivimäki   +6 more
doaj   +2 more sources

Trends in cardiometabolic multimorbidity in non-elderly adult Medicaid enrollees, 2018–2022 [PDF]

Frontiers in Epidemiology
ImportanceMedicaid, as the largest U.S. insurer, can reduce cardiometabolic multimorbidity.ObjectiveAssess patterns and trends in cardiometabolic multimorbidity among Medicaid-enrolled adults.DesignAnalysis of 2018–2022 National Health Interview Survey ...
Puneet Kaur Chehal, Pooja Dilip Lalwani, Erin C. Fuse Brown, Mohammed K. Ali, Solveig A. Cunningham   +4 more
doaj   +2 more sources

Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120 813 adults from 16 cohort studies from the USA and Europe [PDF]

The Lancet Public Health, 2017
Summary: Background: Although overweight and obesity have been studied in relation to individual cardiometabolic diseases, their association with risk of cardiometabolic multimorbidity is poorly understood.
Mika Kivimäki, ProfPhD, Eeva Kuosma, MSc, Jane E Ferrie, PhD, Ritva Luukkonen, PhD, Solja T Nyberg, MSc, Lars Alfredsson, ProfPhD, G David Batty, PhD, Eric J Brunner, PhD, Eleonor Fransson, PhD, Marcel Goldberg, ProfMD, Anders Knutsson, ProfPhD, Markku Koskenvuo, MD, Maria Nordin, PhD, Tuula Oksanen, PhD, Jaana Pentti, MSc, Reiner Rugulies, ProfPhD, Martin J Shipley, MSc, Archana Singh-Manoux, PhD, Andrew Steptoe, ProfPhD, Sakari B Suominen, MD, Töres Theorell, ProfMD, Jussi Vahtera, ProfMD, Marianna Virtanen, ProfPhD, Peter Westerholm, ProfMD, Hugo Westerlund, ProfPhD, Marie Zins, MD, Mark Hamer, ProfPhD, Joshua A Bell, PhD, Adam G Tabak, PhD, Markus Jokela, PhD   +29 more
doaj   +6 more sources

Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors: a multicentre retrospective study (CoViDiab II) [PDF]

Cardiovascular Diabetology, 2020
Background Cardiometabolic disorders may worsen Covid-19 outcomes. We investigated features and Covid-19 outcomes for patients with or without diabetes, and with or without cardiometabolic multimorbidity.
Ernesto Maddaloni, Luca D’Onofrio, Francesco Alessandri, Carmen Mignogna, Gaetano Leto, Giuseppe Pascarella, Ivano Mezzaroma, Miriam Lichtner, Paolo Pozzilli, Felice Eugenio Agrò, Monica Rocco, Francesco Pugliese, Andrea Lenzi, Rury R. Holman, Claudio Maria Mastroianni, Raffaella Buzzetti, the CoViDiab Study Group   +16 more
doaj   +3 more sources

Temporal change in multimorbidity prevalence, clustering patterns, and the association with mortality: findings from the China Kadoorie Biobank study in Jiangsu Province [PDF]

Frontiers in Public Health
ObjectivesThe characteristics of multimorbidity in the Chinese population are currently unclear. We aimed to determine the temporal change in multimorbidity prevalence, clustering patterns, and the association of multimorbidity with mortality from all ...
Hao Yu, Hao Yu, Ran Tao, Jinyi Zhou, Jian Su, Yan Lu, Yujie Hua, Jianrong Jin, Pei Pei, Canqing Yu, Canqing Yu, Canqing Yu, Dianjianyi Sun, Dianjianyi Sun, Dianjianyi Sun, Zhengming Chen, Liming Li, Liming Li, Liming Li, Jun Lv, Jun Lv, Jun Lv   +21 more
doaj   +3 more sources

Socio-geographical disparities in cardiometabolic multimorbidity in Sweden: an Intersectional Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (I-MAIHDA) [PDF]

International Journal for Equity in Health
Background Mapping social and geographical disparities in health outcomes helps to identify vulnerable groups that should be targeted for intervention. This study aims to assess the disparities in cardiometabolic multimorbidity, the presence of at least ...
Kanya Anindya, Juan Merlo, Lars Lind, Lars Weinehall, Marcus Bendtsen, Tomas Jernberg, Maria Rosvall, Nawi Ng   +7 more
doaj   +2 more sources

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. [PDF]

PLoS ONE, 2020
BackgroundIt is now well recognised that the risk of severe COVID-19 increases with some long-term conditions (LTCs). However, prior research primarily focuses on individual LTCs and there is a lack of data on the influence of multimorbidity (≥2 LTCs) on
Ross McQueenie, Hamish M E Foster, Bhautesh D Jani, Srinivasa Vittal Katikireddi, Naveed Sattar, Jill P Pell, Frederick K Ho, Claire L Niedzwiedz, Claire E Hastie, Jana Anderson, Patrick B Mark, Michael Sullivan, Catherine A O'Donnell, Frances S Mair, Barbara I Nicholl   +14 more
doaj   +2 more sources

Longitudinal sequencing of cardiometabolic multimorbidity among older adults and association with subsequent dementia onset. [PDF]

PLoS ONE
BackgroundPatterns of development of cardiometabolic multimorbidity (CMM) and the impact of specific cardiometabolic disease combinations on cognitive function are not well understood.
Corey L Nagel, Siting Chen, Heather G Allore, Anda Botoseneanu, Jason T Newsom, Nick Bishop, David A Dorr, Jeffrey Kaye, Ana R Quiñones   +8 more
doaj   +2 more sources

Remnant cholesterol and body mass index jointly associate with cardiometabolic Multimorbidity with mediation analysis in CHARLS a prospective cohort study [PDF]

Scientific Reports
Remnant cholesterol (RC) has emerged as a novel lipid parameter reflecting the residual risk of atherogenic dyslipidemia beyond low-density lipoprotein cholesterol (LDL-C). Previous studies have demonstrated that elevated RC and increased body mass index
Jiaxin Li, Mingxue Fan, Mingyue Yang, Wei Huang, Wenjing Shi, Daowen Zhang, Weiwei Zhu, Cancan Liu, Nannan Xu, Huijun Zhang, Kuanlu Fan   +10 more
doaj   +2 more sources

Multimorbidity in acute ischemic stroke and its impact on short-term mortality: A Chilean nationwide database analysis [PDF]

Journal of Stroke and Cerebrovascular Diseases
Background: Multimorbidity predicts a worse prognosis for various diseases but its impact in people after an acute ischemic stroke (AIS) in developing societies is not well established. We aimed to characterize the pattern of multimorbidity and determine
Francisca González, MPH PhD(c), Ma. Ignacia Allende, MD, Marilaura Nuñez, MD PhD(c), Iris Delgado, PhD, Paula Jakszyn, PhD, Carlos Delfino, MD PhD(c), Craig S. Anderson, MD PhD, Paula Muñoz Venturelli, MD PhD   +7 more
doaj   +3 more sources